Glipizide
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Glipizida, Glipizidum, Glydiazinamide, Aldiab, Digrin, Dipazide, Glibenese, Glibetin, Glican, Glide, Glidiab, Glipid, Glipizide Extended-Release Tablets, Gluco-Rite, Glucolip, Glucotrol, Glucotrol XL, Glucozide, Glupitel, Glupizide, Glyde, Melizide, Metaglip, Mindiab, Minidab, Minidiab, Minodiab, Napizide, Ozidia, Sucrazide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Dosing and Administration
The usual starting dose of GLUCOTROL XL as initial therapy is 5 mg
per day, given with breakfast. Those patients who may be more sensitive to hypoglycemic drugs
may be started at a lower dose.
Dosage adjustment should be based on laboratory measures of glycemic control. While fasting
blood-glucose levels generally reach steady-state following initiation or change in GLUCOTROL
XL dosage, a single fasting glucose determination may not accurately reflect the response to
therapy. In most cases, hemoglobin A1C level measured at three month intervals is the preferred
means of monitoring response to therapy.
For more information on dosing please refer to Instructions for administration
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Glipizide
Return to top
Publication Resources
Most Recent Articles on Glipizide
Review Articles on Glipizide
Articles on Glipizide in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Glipizide
Return to top
Trial Resources
Ongoing Trials with Glipizide at Clinical Trials.gov
Trial Results with Glipizide
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Glipizide
Cochrane Collaboration on Glipizide
Cost Effectiveness of Glipizide
Return to top
Media Resources
Powerpoint Slides on Glipizide
Images of Glipizide
Podcasts & MP3s on Glipizide
Videos on Glipizide
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Glipizide
Discussion Groups on Glipizide
Patient Handouts on Glipizide
Blogs on Glipizide
Glipizide in the News
Glipizide in the Marketplace
Return to top
International Resources
Glipizide en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.

